Combinative analysis of factors influence serum alanine aminotransferase activity in adult male population from southern China

Clinical Biochemistry

Volumn 45, Issue 18, 2012, Pages 1683-1688

  Liu, Zhengtao ^a   Hu, Yanling ^b   Yang, Xiaobo ^b   Tan, Aihua ^a   Gao, Yong ^a   Qin, Xue ^a   Liang, Yu ^a   Mo, Zengnan ^a   Peng, Tao ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Alanine aminotransferase; Hepatitis B virus; Metabolic syndrome; Nonalcoholic fatty liver disease; Synergic effect

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHINA; ECHOGRAPHY; ENZYME ACTIVITY; HEALTH SURVEY; HUMAN; HYPERLIPIDEMIA; LABORATORY TEST; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PHYSICAL EXAMINATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; CHINA; FATTY LIVER; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; YOUNG ADULT;

EID: 84870661966     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.08.022     Document Type: Article

References (37)

1. Kim W., Flamm S.L., Di Bisceglie A.M., Bodenheimer H.C. Serum activity of alanine aminotransferase (alt) as an indicator of health and disease. Hepatology 2008, 47:1363-1370.
2. Pendino G.M., Mariano A., Surace P., Caserta C.A., Fiorillo M.T., Amante A., et al. Prevalence and etiology of altered liver tests: a population-based survey in a mediterranean town. Hepatology 2005, 41:1151-1159.
3. Jeong S., Nam H., Rhee J., Shin J., Kim J., Cho K. Metabolic syndrome and alt: a community study in adult koreans. Int J Obes 2004, 28:1033-1038.
4. Sorbi D., Boynton J., Lindor K.D. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999, 94:1018-1022.
5. Conry-Cantilena C., VanRaden M., Gibble J., Melpolder J., Shakil A.O., Viladomiu L., et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis c virus infection. N Engl J Med 1996, 334:1691-1696.
6. Green R.M., Flamm S. Aga technical review on the evaluation of liver chemistry tests. Gastroenterology 2002, 123:1367-1384.
7. Bardella M.T., Vecchi M., Conte D., Del Ninno E., Fraquelli M., Pacchetti S., et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology 1999, 29:654-657.
8. Dong M.H., Bettencourt R., Barrett-Connor E., Loomba R. Alanine aminotransferase decreases with age: the rancho bernardo study. PloS One 2010, 5:e14254.
9. Bethel M., Deedwania P., Levitt N., Schmitz O., Huntsman-Labed A., Califf R., et al. Metabolic syndrome and alanine aminotransferase: a global perspective from the navigator screening population. Diabet Med 2009, 26:1204-1211.
10. Burgert T.S., Taksali S.E., Dziura J., Goodman T.R., Yeckel C.W., Papademetris X., et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006, 91:4287-4294.
11. Ioannou G.N., Boyko E.J., Lee S.P. The prevalence and predictors of elevated serum aminotransferase activity in the united states in 1999-2002. Am J Gastroenterol 2006, 101:76-82.
12. Chen C.H., Huang M.H., Yang J.C., Nien C.K., Yang C.C., Yeh Y.H., et al. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in taiwan. J Gastroenterol Hepatol 2007, 22:1482-1489.
13. Hanley A.J.G., Wagenknecht L.E., Festa A., D'Agostino R.B., Haffner S.M. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort. Diabetes Care 2007, 30:1819-1827.
14. Yun J.E., Kim S.Y., Kang H.C., Lee S.J., Kimm H., Jee S.H. Alanine aminotransferase is associated with metabolic syndrome independently of insulin resistance. Circ J 2011, 75:964.
15. Fan J.G., Farrell G.C. Epidemiology of non-alcoholic fatty liver disease in china. J Hepatol 2009, 50:204-210.
16. Lu F., Li T., Liu S., Zhuang H. Epidemiology and prevention of hepatitis b virus infection in china. J Viral Hepat 2010, 17:4-9.
17. Gordon A., McLean C.A., Pedersen J.S., Bailey M.J., Roberts S.K. Hepatic steatosis in chronic hepatitis b and c: predictors, distribution and effect on fibrosis. J Hepatol 2005, 43:38-44.
18. Lu X. Pathogenesis of hepatitis b virus (hbv)-mediated liver injury. North Am J Med Sci Jan. 2011, 4:1.
19. Tan A., Gao Y., Yang X., Zhang H., Qin X., Mo L., et al. Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a chinese male population survey. Metabolism 2011, 60(8):1186-1192.
20. Saverymuttu S., Joseph A., Maxwell J. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res) 1986, 292:13-15.
21. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., McCullough A.J. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-1419.
22. Fan J.G., Saibara T., Chitturi S., Kim B.I., Sung J.J.Y., Chutaputti A. What are the risk factors and settings for non-alcoholic fatty liver disease in asia-pacific?. J Gastroenterol Hepatol 2007, 22:794-800.
23. Matthews D., Hosker J., Rudenski A., Naylor B., Treacher D., Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
24. Rothman K.J. Epidemiology: An Introduction 2002, Oxford University Press, USA.
25. Hosmer D.W., Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992, 452-456.
26. Ekstedt M., Franzén L.E., Mathiesen U.L., Thorelius L., Holmqvist M., Bodemar G., et al. Long-term follow-up of patients with nafld and elevated liver enzymes. Hepatology 2006, 44:865-873.
27. Chitturi S., Farrell G.C., Hashimoto E., Saibara T., Lau G.K.K., Sollano J.D. Non-alcoholic fatty liver disease in the asia-pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007, 22:778-787.
28. Fraser A., Longnecker M.P., Lawlor D.A. Prevalence of elevated alanine aminotransferase among us adolescents and associated factors: Nhanes 1999-2004. Gastroenterology 2007, 133:1814-1820.
29. Saito T., Nishise Y., Makino N., Haga H., Ishii R., Okumoto K., et al. Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the japanese population. Metabolism 2009, 58:1067-1075.
30. Westerbacka J., Corner A., Tiikkainen M., Tamminen M., Vehkavaara S., Häkkinen A.M., et al. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 2004, 47:1360-1369.
31. Garg A., Misra A. Hepatic steatosis, insulin resistance, and adipose tissue disorders. J Clin Endocrinol Metab 2002, 87:3019-3022.
32. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37:917-923.
33. Bugianesi E., Gastaldelli A., Vanni E., Gambino R., Cassader M., Baldi S., et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005, 48:634-642.
34. Pagano G., Pacini G., Musso G., Gambino R., Mecca F., Depetris N., et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002, 35:367-372.
35. Fang Z.L., Harrison T.J., Yang J.Y., Chen Q.Y., Wang X.Y., Mo J.J. Prevalence of hepatitis b virus infection in a highly endemic area of southern china after catch-up immunization. J Med Virol 2012, 84:878-884.
36. Altlparmak E., Koklu S., Yalinkilic M., Yuksel O., Cicek B., Kayacetin E., et al. Viral and host causes of fatty liver in chronic hepatitis b. World J Gastroenterol 2005, 11:3056.
37. Lu J., Zhou Y., Lin X., Jiang Y., Tian R., Zhang Y., et al. General epidemiological parameters of viral hepatitis a, b, c, and e in six regions of china: a cross-sectional study in 2007. PLoS One 2009, 4:e8467.